These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1754608

  • 1. Adinazolam, diazepam, imipramine, and placebo in major depressive disorder: a controlled study.
    Rickels K, London J, Fox I, Hassman H, Csanalosi I, Weise C.
    Pharmacopsychiatry; 1991 Jul; 24(4):127-31. PubMed ID: 1754608
    [Abstract] [Full Text] [Related]

  • 2. Comparison of adinazolam, amitriptyline, and diazepam in endogenous depressive inpatients exhibiting DST nonsuppression or abnormal contingent negative variation.
    Ansseau M, Devoitille JM, Papart P, Vanbrabant E, Mantanus H, Timsit-Berthier M.
    J Clin Psychopharmacol; 1991 Jun; 11(3):160-5. PubMed ID: 2066454
    [Abstract] [Full Text] [Related]

  • 3. Adinazolam--a new antidepressant: findings of a placebo-controlled, double-blind study in outpatients with major depression.
    Dunner D, Myers J, Khan A, Avery D, Ishiki D, Pyke R.
    J Clin Psychopharmacol; 1987 Jun; 7(3):170-2. PubMed ID: 3298327
    [Abstract] [Full Text] [Related]

  • 4. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A, Fouilloux C, Ortiz S.
    Proc West Pharmacol Soc; 2002 Jun; 45():154-5. PubMed ID: 12434564
    [No Abstract] [Full Text] [Related]

  • 5. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM.
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [Abstract] [Full Text] [Related]

  • 6. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.
    Amsterdam JD, Kaplan M, Potter L, Bloom L, Rickels K.
    Psychopharmacology (Berl); 1986 Mar; 88(4):484-8. PubMed ID: 3085137
    [Abstract] [Full Text] [Related]

  • 7. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB, Crowder JE, Wilcox CS, Ryan PJ.
    Psychopharmacol Bull; 1990 Mar; 26(2):185-9. PubMed ID: 2146697
    [Abstract] [Full Text] [Related]

  • 8. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J, Schless AP.
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [Abstract] [Full Text] [Related]

  • 9. Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
    Montgomery SA, Baldwin DS, Priest RG, Steinert J, Patel A, Herrington RN, Livingston HM.
    Pharmacopsychiatry; 1991 Sep; 24(5):168-74. PubMed ID: 1775522
    [Abstract] [Full Text] [Related]

  • 10. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 11. A review of controlled studies of adinazolam mesylate in patients with major depressive disorder.
    Feighner JP.
    Psychopharmacol Bull; 1986 Feb; 22(1):186-91. PubMed ID: 3523576
    [No Abstract] [Full Text] [Related]

  • 12. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP, Boyer WF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [Abstract] [Full Text] [Related]

  • 13. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E, Feighner J, Mandos LA, Rickels K.
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [Abstract] [Full Text] [Related]

  • 14. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD.
    Psychopharmacol Bull; 1996 Mar; 32(4):659-65. PubMed ID: 8993088
    [Abstract] [Full Text] [Related]

  • 15. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
    Weissman MM, Prusoff B, Sholomskas AJ, Greenwald S.
    J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
    [Abstract] [Full Text] [Related]

  • 16. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK, Shrivastava SH, Overweg N, Blumhardt CL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [Abstract] [Full Text] [Related]

  • 17. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [Abstract] [Full Text] [Related]

  • 18. Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder.
    Bakish D, Lapierre YD, Weinstein R, Klein J, Wiens A, Jones B, Horn E, Browne M, Bourget D, Blanchard A.
    J Clin Psychopharmacol; 1993 Dec; 13(6):409-14. PubMed ID: 8120154
    [Abstract] [Full Text] [Related]

  • 19. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
    Hebenstreit GF, Fellerer K, Fichte K, Fischer G, Geyer N, Meya U, Sastre-y-Hernández M, Schöny W, Schratzer M, Soukop W.
    Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
    [Abstract] [Full Text] [Related]

  • 20. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP, Galinowski A, Lehert P, Lemonnier F, Lôo H.
    Encephale; 1993 Jul; 19(4):333-40. PubMed ID: 8275921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.